http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5055295-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edfc44027af57d02fc84fe2aa383fcaa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 1989-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1991-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e099b9177f142e5e0768ad9db6b7a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6943400a2e5fb2fb9e6b55ea310d195
publicationDate 1991-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5055295-A
titleOfInvention Lysis of fibrin blood clots with urokinase and pro-urokinase
abstract The thrombolytic effect of the plasminogen activator pro-urokinase is improved synergistically by the co-administration of urokinase. The two components may be administered sequentially or simultaneously, and if simultaneously, either separately or as a mixture. Preferably an initial bolus injection of urokinase is followed by an infusion of pro-urokinase.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5138446-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2281569-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5416006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009136557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11213574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010143325-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5688503-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007148160-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6759042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016073514-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5626841-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021080262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009226413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2281569-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7837992-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3708226-A1
priorityDate 1986-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4286063-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3926727-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE32271-E
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238

Total number of triples: 45.